by Gary Cooke | Jul 2, 2019 | News
Jenny Howell joins Thirty Group as Chief Operating Officer. Jenny has more than 20 years’ experience in the biotech and pharmaceutical industry, most recently with AstraZeneca/MedImmune where she held a number of senior leadership positions including Chief of Staff to...
by Gary Cooke | Jun 25, 2019 | News, Uncategorised
Thirty Group is delighted to announce the opening of its new Research Centre at Milton Park, Oxford. The facility will house clinical, research, development and regulatory activities for our revolutionary 30Technology™ across Regenerative Medicine, Respiratory and...
by Gary Cooke | Jun 3, 2019 | News
John Efthimiou BSc MD FRCP is a respiratory specialist physician/scientist trained in London and Oxford teaching hospitals, accredited in both Respiratory and General Medicine. He joined Thirty Group in June 2019 and has over 25 years’ experience in and advising large...
by 30 Technology | Nov 1, 2018 | News
Thirty Holdings Limited completed a £25 million equity investment led by Morningside Ventures, a major investor in the global Life Science sector. The investment enables the Group to accelerate research and development. We are delighted to welcome Isaac Cheng to the...
by 30 Technology | Oct 1, 2018 | News
Thirty Holdings Limited established following a corporate restructure. The Company trading name will be 30 Technology with the name derived from the molecular weight of nitric oxide (30). Edixomed Limited is now a wholly owned subsidiary of Thirty Holdings, focusing...
by 30 Technology | Apr 1, 2018 | News
New results show that Edixomed’s revolutionary new wound care system, EDX110, can heal diabetic foot ulcers dramatically faster and more effectively than current standard care. “Diabetic foot ulcers are notoriously hard to heal and are the leading cause of...
Recent Comments